Anemia in the elderly: Current understanding and emerging concepts

Blood Reviews

Volumn 20, Issue 4, 2006, Pages 213-226

  Eisenstaedt, Richard ^a   Penninx, Brenda W J H ^b   Woodman, Richard C ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Ortho Biotech Products LP   (United States)

Author keywords

Anemia; Erythropoietin

Indexed keywords

CYANOCOBALAMIN; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FERRITIN; FOLIC ACID; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN BINDING PROTEIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR;

ACUTE HEART INFARCTION; AGING; ANEMIA; ARTICLE; BONE DENSITY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG MECHANISM; DRUG TOLERABILITY; FALLING; FERRITIN BLOOD LEVEL; FRACTURE; FRAIL ELDERLY; GASTROINTESTINAL DISEASE; HEMATOPOIESIS; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; IRON DEFICIENCY ANEMIA; MORTALITY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUALITY OF LIFE; RISK FACTOR; THROMBOSIS; UNSPECIFIED SIDE EFFECT; UPREGULATION;

AGED; AGED, 80 AND OVER; AGING; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; MALE; QUALITY OF LIFE;

EID: 33646593198     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2005.12.002     Document Type: Article

References (122)

1. Nandigam V., Nandigam K., Badhe B.A., and Dutta T.K. Is adult definition of anemia applicable to a geriatric population? Study of erythrocyte parameters in Indian geriatric inpatients. J Am Geriatr Soc 52 (2004) 1589-1590
2. Chaves P.H., Xue Q.L., Guralnik J.M., Ferrucci L., Volpato S., and Fried L.P. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc 52 (2004) 1811-1816
3. Penninx B.W., Pahor M., Cesari M., Corsi A.M., Woodman R.C., Bandinelli S., et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 52 (2004) 719-724
4. Chaves P.H., Ashar B., Guralnik J.M., and Fried L.P. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated. J Am Geriatr Soc 50 (2002) 1257-1264
5. Ershler W.B., Sheng S., McKelvey J., Artz A.S., Denduluri N., Tecson J., et al. Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc 53 (2005) 1360-1365
6. National Health and Nutrition Examination Survey. Anthropometric Reference Data, United States. 1988-1994. Available at: http://www.cdc.gov/nchs/about/major/nhanes/Anthropometric%20Measures. htm. Accessed December 5, 2005.
7. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
8. Fleming D.J., Jacques P.F., Tucker K.L., Massaro J.M., D'Agostino Sr. R.B., Wilson P.W., et al. Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr 73 (2001) 638-646
9. Artz A.S., Fergusson D., Drinka P.J., Gerald M., Bidenbender R., Lechich A., et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 52 (2004) 423-427
10. Izaks G.J., Westendorp R.G., and Knook D.L. The definition of anemia in older persons. JAMA 281 (1999) 1714-1717
11. Olivares M., Hertrampf E., Capurro M.T., and Wegner D. Prevalence of anemia in elderly subjects living at home: role of micronutrient deficiency and inflammation. Eur J Clin Nutr 54 (2000) 834-839
12. Inelmen E.M., D'Alessio M., Gatto M.R., Baggio M.B., Jimenez G., Bizzotto M.G., et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home: some results of an Italian multicentric study. Aging (Milano) 6 (1994) 81-89
13. Beutler E., and West C. Hematologic differences between African-Americans and whites: the roles of iron deficiency and {alpha}-thalassemia on hemoglobin levels and MCV. Blood 106 (2005) 740-745
14. Rimon E., Levy S., Sapir A., Gelzer G., Peled R., Ergas D., et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med 162 (2002) 445-449
15. Milman N., Pedersen A.N., Ovesen L., and Schroll M. Iron status in 358 apparently healthy 80- year-old Danish men and women: relation to food composition and dietary and supplemental iron intake. Ann Hematol 83 (2004) 423-429
16. Smith D.L. Anemia in the elderly. Am Fam Physician 62 (2000) 1565-1572
17. Rockey D.C., and Cello J.P. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 329 (1993) 1691-1695
18. Spivak J.L. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer 5 (2005) 543-555
19. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
20. Cartwright C.E. The anemia of chronic disorders. Sem Hematol 3 (1966) 351-375
21. Means Jr. R.T., and Krantz S.B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80 (1992) 1639-1647
22. Burns E.R., Goldberg S.N., Lawrence C., and Wenz B. Clinical utility of serum tests for iron deficiency in hospitalized patients. Am J Clin Pathol 93 (1990) 240-245
23. Jacobs A., and Worwood M. Ferritin in serum: clinical and biochemical implications. N Engl J Med 292 (1975) 951-956
24. Guyatt G.H., Oxman A.D., Ali M., Willan A., McIlroy W., and Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 7 (1992) 145-153
25. Coenen J.L., van Dieijen-Visser M.P., van Pelt J., van Deursen C.T., Fickers M.M., van Wersch J.W., et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem 37 (1991) 560-563
26. Hansen T.M., Hansen N.E., Birgens H.S., Holund B., and Lorenzen I. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 12 (1983) 353-359
27. Witte D.L. Can serum ferritin be effectively interpreted in the presence of the acute-phase response?. Clin Chem 37 (1991) 484-485
28. Kurer S.B., Seifert B., Michel B., et al. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia. Br J Haematol 91 (1995) 820-826
29. Krause J.R., Brubaker D., and Kaplan S. Comparison of stainable iron in aspirated and needle-biopsy specimens of bone marrow. Am J Clin Pathol 72 (1979) 68-70
30. Punnonen K., Irjala K., and Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997) 1052-1057
31. Suominen P., Mottonen T., Rajamaki A., and Irjala K. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 43 (2000) 1016-1020
32. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. The prevalence of anemia in persons age 65 and older in the United States: evidence for a high rate of idiopathic anemia of aging (IAA). Blood 102 (2003) 17b
33. Tilg H., Ulmer H., Kaser A., and Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol 169 (2002) 2204-2209
34. Faquin W.C., Schneider T.J., and Goldberg M.A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79 (1992) 1987-1994
35. Nordstrom D., Lindroth Y., Marsal L., Hafstrom I., Henrich C., Rantapaa-Dahlqvist S., et al. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis. Rheumatol Int 17 (1997) 67-73
36. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
37. Roy C.N., Weinstein D.A., and Andrews N.C. 2002 E.Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res 53 (2003) 507-512
38. Jongen-Lavrencic M., Peeters H.R., Wognum A., Vreugdenhil G., Breedveld F.C., and Swaak A.J. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 24 (1997) 1504-1509
39. Papadaki H.A., Kritikos H.D., Valatas V., Boumpas D.T., and Eliopoulos G.D. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100 (2002) 474-482
40. Silva M., Grillot D., Benito A., Richard C., Nunez G., and Fernandez-Luna J.L. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88 (1996) 1576-1582
41. Spivak J.L. The blood in systemic diseases. Lancet 355 (2000) 1707-1712
42. Baer A.N., Dessypris E.N., Goldwasser E., and Krantz S.B. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66 (1987) 559-564
43. Miller C.B., Jones R.J., Piantadosi S., Abeloff M.D., and Spivak J.L. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322 (1990) 1689-1692
44. Remacha A.F., Rodriguez-de la Serna A., Garcia-Die F., Geli C., Diaz C., and Gimferrer E. Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. J Rheumatol 19 (1992) 1687-1691
45. Spivak J.L., Barnes D.C., Fuchs E., and Quinn T.C. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261 (1989) 3104-3107
46. Cazzola M., Mercuriali F., and Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 89 (1997) 4248-4267
47. Pettersson T., Rosenlof K., Friman C., Mickos A., Teppo A.M., and Fyhrquist F. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol 22 (1993) 188-193
48. Pincus T., Olsen N.J., Russell I.J., Wolfe F., Harris E.R., Schnitzer T.J., et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89 (1990) 161-168
49. Salvarani C., Lasagni D., Casali B., Macchioni P., Boiardi L., Rossi F., et al. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol 18 (1991) 1168-1171
50. Peeters H.R., Jongen-Lavrencic M., Vreugdenhil G., and Swaak A.J. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis 55 (1996) 739-744
51. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 92 Suppl 6 (2001) 1684-1688
52. Ershler W.B. Biological interactions of aging and anemia: a focus on cytokines. J Am Geriatr Soc 51 Suppl 3 (2003) S18-S21
53. Cooper A.C., Mikhail A., Lethbridge M.W., Kemeny D.M., and Macdougall I.C. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 14 (2003) 1776-1784
54. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
55. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
56. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
57. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110 (2002) 1037-1044
58. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
59. Papanikolaou G., Tzilianos M., Christakis J.I., Bogdanos D., Tsimirika K., MacFarlane J., et al. Hepcidin in iron overload disorders. Blood 105 (2005) 4103-4105
60. Krijt J., Vokurka M., Chang K.T., and Necas E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104 (2004) 4308-4310
61. Skikne B.S., Flowers C.H., and Cook J.D. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75 (1990) 1870-1876
62. Pettersson T., Teppo A.M., and Siimes M.A. Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis. Scand J Rheumatol 25 (1996) 321-324
63. Cook J.D. The measurement of serum transferrin receptor. Am J Med Sci 318 (1999) 269-276
64. Patterson C., Turpie I.D., and Benger A.M. Assessment of iron stores in anemic geriatric patients. J Am Geriatr Soc 33 (1985) 764-767
65. Genc S., Erten N., Karan M.A., Besisik S.K., Saka B., Tascioglu C., et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients. Tohoku J Exp Med 202 (2004) 135-142
66. Loria A., Hershko C., and Konijn A.M. Serum ferritin in an elderly population. J Gerontol 34 (1979) 521-524
67. Kario K., Matsuo T., and Nakao K. Serum erythropoietin levels in the elderly. Gerontology 37 (1991) 345-348
68. Carpenter M.A., Kendall R.G., O'Brien A.E., Chapman C., Sebastian J.P., Belfield P.W., et al. Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia. Eur J Haematol 49 (1992) 119-121
69. Kario K., Matsuo T., Kodama K., Nakao K., and Asada R. Reduced erythropoietin secretion in senile anemia. Am J Hematol 41 (1992) 252-257
70. Nafziger J., Pailla K., Luciani L., Andreux J.P., Saint-Jean O., and Casadevall N. Decreased erythropoietin responsiveness to iron deficiency anemia in the elderly. Am J Hematol 43 (1993) 172-176
71. Carmel R. Anemia and aging: an overview of clinical, diagnostic and biological issues. Blood Rev 15 (2001) 9-18
72. Leng S., Chaves P., Koenig K., and Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50 (2002) 1268-1271
73. Collins A.J., Li S., Gilbertson D.T., Liu J., Chen S.C., and Herzog C.A. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 87 (2003) S24-S31
74. McClellan W., Aronoff S.L., Bolton W.K., Hood S., Lorber D.L., Tang K.L., et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20 (2004) 1501-1510
75. De Marchi S., Pirisi M., and Ferraccioli G.F. Erythropoietin and the anemia of chronic diseases. Clin Exp Rheumatol 11 (1993) 429-444
76. Ble A., Fink J.C., Woodman R.C., Klausner M.A., Windham B.G., Guralnik J.M., et al. Renal function, erythropoietin and anemia of older persons : the InCHIANTI study. Arch Intern Med 165 (2005) 2222-2227
77. Ferrucci L., Guralnik J.M., Woodman R.C., Bandinelli S., Lauretani F., Corsi A.M., et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118 (2005) 1288-1296
78. Balducci L., and Hardy C.L. Anemia of aging: a model of erythropoiesis in cancer patients. Cancer Control 5 Suppl 1 (1998) 17-21
79. Balducci L. Anemia, cancer, and aging. Cancer Control 10 (2003) 478-486
80. Giuliani N., Sansoni P., Girasole G., Vescovini R., Passeri G., Passeri M., et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 36 (2001) 547-557
81. Ferrucci L., Guralnik J.M., Woodman R.C., Bandinelli S., Lauretani F., Corsi A., et al. Circulating erythropoietin (EPO) and pro-inflammatory markers in elderly ({greater than or slanted equal to}65) persons with and without anemia. Blood 104 (2004) 453a (abstract 1629)
82. Ferrucci L., and Guralnik J.M. Inflammation, hormones, and body composition at a crossroad. Am J Med 115 (2003) 501-502
83. Dharmarajan T.S., Avula S., Jayakrishnan L., and Joseph P. Mild anemia increases the risk of falls in hospitalized older adults. J Am Geriatr Soc 53 Suppl 4 (2005) S94
84. Woodman R., Ferrucci L., and Guralnik J. Anemia in older adults. Curr Opin Hematol 12 (2005) 123-128
85. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc 51 Suppl 3 (2003) S10-S13
86. Kikuchi M., Inagaki T., and Shinagawa N. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc 49 (2001) 1226-1228
87. Penninx BW, Pahor M, Woodman RC, Ferrucci L, Guralnik JM. Late-life anemia identifies persons at risk for mortality and hospitalization. J Gerontol Med Sci 2006, in press.
88. Zakai N.A., Katz R., Hirsch C., Shlipak M.G., Chaves P.H., Newman A.B., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 165 (2005) 2214-2220
89. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
90. Silverberg D.S., Wexler D., and Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?. J Nephrol 17 (2004) 749-761
91. Sharma R., Francis D.P., Pitt B., Poole-Wilson P.A., Coats A.J., and Anker S.D. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 25 (2004) 1021-1028
92. Nair D., Shlipak M.G., Angeja B., Liu H.H., Schiller N.B., and Whooley M.A. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol 95 (2005) 332-336
93. Amin M.G., Tighiouart H., Weiner D.E., Stark P.C., Griffith J.L., MacLeod B., et al. Hematocrit and left ventricular mass: the Framingham Heart study. J Am Coll Cardiol 43 (2004) 1276-1282
94. Astor B.C., Arnett D.K., Brown A., and Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 43 (2004) 836-845
95. Chaves P.H., Semba R.D., Leng S.X., Woodman R.C., Ferrucci L., Guralnik J.M., et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 60 (2005) 729-735
96. Guse C.E., and Porinsky R. Risk factors associated with hospitalization for unintentional falls: Wisconsin hospital discharge data for patients aged 65 and over. WMJ 102 (2003) 37-42
97. Dharmarajan T.S., and Norkus E.P. Mild anemia and the risk of falls in older adults from nursing homes and the community. J Am Med Dir Assoc 5 (2004) 395-400
98. Duh M.S., Lefebvre P., Buteau S., Mody S.H., and Woodman R. Anemia and risk of accidental falls/fractures in the elderly. J Am Geriatr Soc 53 Suppl 4 (2005) S8-S83
99. Penninx B.W., Pluijm S.M., Lips P., Woodman R., Miedema K., Guralnik J.M., et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 53 (2005) 2106-2111
100. Gruson K.I., Aharonoff G.B., Egol K.A., Zuckerman J.D., and Koval K.J. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 16 (2002) 39-44
101. Argyriadou S., Vlachonikolis I., Melisopoulou H., Katachanakis K., and Lionis C. In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece. BMC Fam Pract 2 (2001) 5
102. Chaves P.H., Carlson M.C., and Fried L.P. Cognitive function in high functioning older women: does hemoglobin concentration matter. J Am Geriatr Soc 50 Suppl 4 (2002) S149-S150
103. Zamboni V, Cesari M, Zuccala G, Onder G, Woodman RC, Maraldi C, et al. Anemia and cognitive performance in hospitalized older patients: results from the GIFA study. Int J Geriatr Psychiatry 2006, in press.
104. Myers E., Grady P.O., and Dolan A.M. The influence of preclinical anaemia on outcome following total hip replacement. Arch Orthop Trauma Surg 124 (2004) 699-701
105. Sabbatini P. The relationship between anemia and quality of life in cancer patients. Oncologist 5 Suppl 2 (2000) 19-23
106. Ross S.D., Fahrbach K., Frame D., Scheye R., Connelly J.E., and Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review. Clin Ther 25 (2003) 1786-1805
107. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 13 (2002) 389-391
108. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., et al. The origins of age-related proinflammatory state. Blood 105 (2005) 2294-2299
109. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51 (2000) 245-270
110. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80
111. Papadopoulos N.G., Georganas K., Skoutellas V., Konstantellos E., and Lyritis G.P. Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol 16 (1997) 162-165
112. Penninx B.W., Guralnik J.M., Onder G., Ferrucci L., Wallace R.B., and Pahor M. Anemia and decline in physical performance among older persons. Am J Med 115 (2003) 104-110
113. Cesari M., Penninx B.W., Lauretani F., et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59 (2004) 249-254
114. Cesari M., Pahor M., Lauretani F., Penninx B.W., Bartali B., Russo R., et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int 16 (2005) 691-699
115. Means Jr. R.T., Olsen N.J., Krantz S.B., Dessypris E.N., Graber S.E., Stone W.J., et al. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 32 (1989) 638-642
116. Fischl M., Galpin J.E., Levine J.D., Groopman J.E., Henry D.H., Kennedy P., et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322 (1990) 1488-1493
117. Abels R. Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A Suppl 2 (1993) S2-S8
118. Glaspy J., Bukowski R., Steinberg D., Taylor C., Tchekmedyian S., and Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15 (1997) 1218-1234
119. Schreiber S., Howaldt S., Schnoor M., Nikolaus S., Bauditz J., Gasche C., et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334 (1996) 619-623
120. Ershler W.B., Artz A.S., and Kandahari M.M. Recombinant erythropoietin treatment of anemia in older adults. J Am Geriatr Soc 49 (2001) 1396-1397
121. Grimley C.E., Crouch D., and Dolan G. Correction of anaemia of chronic disease (ACD) with small doses of recombinant erythropoietin[abstract]. Br J Haematol 121 Suppl 1 (2003) 95
122. Agnihotri P., Ahuja M., Telfer M.C., et al. Chronic anemia and fatigue in elderly patients: results of the first randomized double-blind placebo-controlled cross-over study with epoetin alfa. Blood 106 (2005) Abstract #3553